- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01598818
First-Sight Refractive Error Correction in the Developing World
Study Overview
Status
Conditions
Detailed Description
In remote and underserved areas, a patient may have limited or no access to eye specialists or healthcare facilities that offer equipment to provide standard refraction and purchase corrective lenses. First Sight Refracting system (FSR) is designed specifically to be used in remote and underserved areas. FSR is not considered the standard of care in the US. FSR is a portable refraction and lens-frame dispensing system with low cost of production. As a kit, it contains +/- 6.00 diopters of corrective lenses, color coordinated flipper, - 1.25 diopter astigmatism lens, visual acuity chart, astigmatic eye chart, measuring tape to measure the distance of the subject to the eye charts, pupillary distance ruler to measure for the frame size of the glasses to be dispensed, and lint free gloves. The kit comes with two standard frames. The corrective lenses are designed to be placed in the frames that can be readily dispensed to the patient after the refraction is done. The refraction technique is simple and straightforward and any healthcare worker in remote and underserved areas can provide the test and dispense glasses at no cost.
This is the third phase of First Sight refractive study to be done in Haiti. Adult and children subjects will be recruited during their routine examinations and/or visual acuity screenings at the Justinien Hospital. The proposed study will compare the visual acuity measurements obtained from the First Sight refraction system (test procedure) with the visual acuity measurements obtained from the autorefraction (standard care). The international study will recruit 150 subjects which will test FSR's effectiveness as a refracting tool of choice to be used in remote and underserved areas. Data from this study will be compared with the US studies.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Cap-Haïtien, Haiti
- Justinien Hospital
-
-
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198-5540
- University of Nebraska Medical Center, Department of Ophthalmology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subjects must be 7 years of age and older
- Healthy subjects with no known ocular trauma, no surgery, ocular disease or pathology that would prevent obtainment of best correctable visual acuity to 20/30.
Exclusion Criteria:
- Refractive error greater than (+)/(-) 6.00 diopter, or astigmatism greater than 1.50 diopters.
- Known ocular (corneal, lenticular, vitreal, or retinal) pathology that may limit best correctable visual acuity.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Visual acuity
Comparison of best visual acuity and refraction using the First Sight Refractive System with autorefraction in subjects with refractive error.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To compare the best visual acuity and refraction results using the First Sight Refraction System to standard auto-refraction in subjects with hyperopia.
Time Frame: 1 month
|
A refractive error of +0.50 to +4.50 diopter spherical error and asitgmatism of 1.50 diopters will be assessed.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To compare the best visual acuity and refraction results using the First Sight Refractive System to autorefraction in myopia.
Time Frame: 1 month
|
A refractive error of -0.50 to -4.50 diopter spherical error and up to 1.50 astigmatism will be compared.
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Feilmeier, MD, University of Nebraska Medical Center, Department of Ophthalmology and Visual Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0553-11-FB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vision Loss
-
Ocuphire Pharma, Inc.Ophthalmic Consultants of Long IslandCompletedDecrease in Night Vision | Disturbance; Vision, LossUnited States
-
University Hospital Hradec KraloveUnknown
-
Sun Yat-sen UniversityRecruiting
-
Ocuphire Pharma, Inc.CompletedNight Vision Complaints | Decrease in Night Vision | Disturbance; Vision, LossUnited States
-
VA Office of Research and DevelopmentCompletedCentral Vision Loss From Macular DiseasesUnited States
-
Ocuphire Pharma, Inc.Viatris Inc.RecruitingMesopic Vision | Night Vision LossUnited States
-
Lille Catholic UniversityUniversity Hospital, LilleCompleted
-
State University of New York College of OptometryState University of New York College of OptometryRecruitingQuality of Life | Visual Impairment | Functional Visual Loss | Low Vision BlindnessUnited States
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Radboud University Medical CenterCompleted